We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

78 hedge funds and large institutions have $71.9M invested in abrdn Life Sciences Investors in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 20

0.01% more ownership

Funds ownership: 20.75% → 20.76% (+0.01%)

3% less capital invested

Capital invested by funds: $73.9M → $71.9M (-$2.07M)

3% less funds holding

Funds holding: 80 → 78 (-2)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
78
Holders Change
-2
Holders Change %
-2.5%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
32
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.24M
2
1CP
1607 Capital Partners
Virginia
+$1.06M
3
Allspring Global Investments
Allspring Global Investments
North Carolina
+$897K
4
RJA
Raymond James & Associates
Florida
+$782K
5
AA
AQR Arbitrage
Connecticut
+$572K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$2.27M
2
AAM
Advisors Asset Management
Colorado
-$1.22M
3
Bank of America
Bank of America
North Carolina
-$784K
4
Millennium Management
Millennium Management
New York
-$702K
5
WAM
Weiss Asset Management
Massachusetts
-$403K
Name Holding Trade Value Shares
Change 		Change in
Stake
CWS
51
Cypress Wealth Services
California
$149K +$153K +10,674 New
IWM
52
IHT Wealth Management
Illinois
$143K – – –
QCIG
53
Quad-Cities Investment Group
Iowa
$141K -$7.72K -540 -5%
PA
54
Parallel Advisors
California
$138K +$1.07K +75 +0.8%
GRP
55
Global Retirement Partners
California
$67.6K +$1.66K +116 +2%
CSPIA
56
Cary Street Partners Investment Advisory
Virginia
$54.2K – – –
ASN
57
Advisory Services Network
Georgia
$50.7K – – –
CWC
58
Carolinas Wealth Consulting
North Carolina
$48.3K – – –
CFD
59
Creative Financial Designs
Indiana
$30.6K +$31.4K +2,200 New
IAIM
60
International Assets Investment Management
Florida
$21K +$21.5K +1,507 New
SPIA
61
Steward Partners Investment Advisory
New York
$20.7K +$500 +35 +2%
BBPWM
62
Blue Bell Private Wealth Management
Pennsylvania
$19.7K -$15K -1,046 -43%
BAM
63
Belpointe Asset Management
Nevada
$18K – – –
HGERS
64
Householder Group Estate & Retirement Specialist
Arizona
$15K +$15.3K +1,070 New
Carson Wealth (CWM LLC)
65
Carson Wealth (CWM LLC)
Nebraska
$14K – – –
Bessemer Group
66
Bessemer Group
New Jersey
$13K -$2.04K -143 -13%
PFG
67
Piershale Financial Group
Illinois
$11.4K +$286 +20 +3%
WBC
68
West Branch Capital
Massachusetts
$10.3K +$257 +18 +3%
HNB
69
Huntington National Bank
Ohio
$7.16K – – –
BWS
70
Buck Wealth Strategies
Colorado
$6.55K +$6.72K +470 New
LFG
71
Larson Financial Group
Missouri
$5.98K – – –
ACA
72
Atlas Capital Advisors
Wyoming
$1.92K – – –
FCT
73
First Community Trust
Iowa
$1.39K – – –
Commonwealth Equity Services
74
Commonwealth Equity Services
Massachusetts
$833 -$17K -1,192 -2%
Northwestern Mutual Wealth Management
75
Northwestern Mutual Wealth Management
Wisconsin
$529 +$543 +38 New
1 2
3
4

HQL Hedge Fund Activity: Q1 2023 in Review

78 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2023, worth a combined $71.9M — down 2.8% from $73.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of HQL and 8 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 32 added.

The largest buyer was Morgan Stanley, adding an estimated $1.24M. The largest seller was Wells Fargo, cutting an estimated $2.27M.

  • 78 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2023, down from 80 in Q4 2022.
  • Funds reported $71.9M of abrdn Life Sciences Investors stock for Q1 2023, down 2.8% quarter-over-quarter.
  • 8 funds opened new abrdn Life Sciences Investors positions in Q1 2023 and 9 closed out, a net change of -1 holder.
  • The largest abrdn Life Sciences Investors buyer in Q1 2023 was Morgan Stanley, an estimated $1.24M added.
  • The largest abrdn Life Sciences Investors seller in Q1 2023 was Wells Fargo, an estimated $2.27M sold.

Based on aggregated 13F filings for Q1 2023.